The mechanism of phosphaturia induced by cAMP infusion and the physiological role ofextracellular cAMP in modulation of renal phosphate transport were examined. In cultured opossum kidney cells, extracellular cAMP (10-1,000 AM) inhibited Na-dependent phosphate uptake in a time-and concentration-dependent manner. The effect ofcAMP was reproduced by ATP, AMP, and adenosine, and was blunted by phosphodiesterase inhibitors or by dipyridamole which inhibits adenosine uptake. I3HIcAMP was degraded extracellularly into AMP and adenosine, and radioactivity accumulated in the cells as labeled adenosine and, subsequently, as adenine nucleotides including cAMP. Radioactivity accumulation was decreased by dipyridamole and by inhibitors of phosphodiesterases and ecto-5'-nucleotidase, assessing the existence of stepwise hydrolysis of extracellular cAMP and intracellular processing of taken up adenosine. In vivo, dipyridamole abolished the phosphaturia induced by exogenous cAMP infusion in acutely parathyroidectomized (APTX) rats, decreased phosphate excretion in intact rats, and blunted phosphaturia induced by PTH infusion in APTX rats. These results indicate that luminal degradation of cAMP into adenosine, followed by cellular uptake of the nucleoside by tubular cells, is a key event which accounts for the phosphaturic effect of exogenous cAMP and for the part of the phosphaturic effect of PITH which is mediated by cAMP added to the tubular lumen under the influence of the hormone. (J.
Introduction
Cyclic adenosine 3 ',5 '-monophosphate (cAMP) is currently acknowledged as a second intracellular messenger involved in signal transduction for peptidic hormones, including parathyroid hormone (PTH). Increased generation of cAMP is, together with phosphoinositide breakdown, one of the events which lead to PTH inhibition ofsodium-Pi cotransport in renal brush border membranes, the initial step of Pi reabsorption in the renal proximal tubule (1) (2) (3) (4) . One unique feature of PTH action in the proximal tubule, but not in other renal target sites of the hormone (i.e., cortical ascending limb of Henle's loop and distal convoluted tubule), is that a substantial part of generated cAMP is transferred from the cells into the tubular lumen through the apical membranes (5) . Consequently, excreted cAMP in the urine is approximately twice the filtered cAMP load (6) . The difference between excreted and filtered cAMP, i.e., nephrogenous cAMP, is a reliable index ofparathyroid function because it is elevated over normal values during hyperparathyroidism (6) and it is equal to zero in acutely parathyroidectomized (APTX)' animals in which Pi excretion is abolished or decreased (7) . The question of whether luminal cyclic AMP per se may influence Pi reabsorption has not been adequately addressed. However, it has been clearly established that the phosphaturic effect of PTH could be mimicked, in vivo, by systemic infusion of cAMP to APTX animals (8, 9) when plasma concentration of cAMP was increased to the micromolar range. Interestingly, other renal effects of PTH, such as those exerted on the loop of Henle or on the distal tubule, were not reproduced by cAMP infusion (8, 9) . Moreover, infused cAMP did not mimick the renal effects of other peptidic hormones, such as antidiuretic hormone (8, 9) .
These results raise the possibility that handling (i.e., metabolism and/or transport) of extracellular cAMP by proximal tubular cells was involved in the effects ofthe cyclic nucleotide. However, the involved mechanism has not been fully elucidated. That extracellular cAMP could enter proximal cells at their basal pole, through an organic anion transporter, has been proposed (10, 11) . However, evidence that cAMP has a very low affinity, in the millimolar range (1 1, 12) , for this transporter makes this hypothesis unlikely. Alternatively, proximal tubules in suspension were shown to metabolize extracellular cAMP and to uptake degradation products (13) , especially adenosine. Adenosine uptake by tubular cells has been extensively characterized (14) (15) (16) (17) and was reported to play a central role in the protective effect of adenine nucleotides on tubular function during and after anoxia ( 18) .
The aim ofthe present study was: (a) to elucidate the mechanism by which extracellular cAMP inhibits proximal tubular Pi transport and (b) to evaluate the extent to which extracellular cAMP, added to the tubular lumen under the influence of PTH, participates to the overall phosphaturic effect of the hormone.
1. Abbreviations used in this paper: APTX, acutely parathyroidectomized; bPTH, bovine PTH; dBcAMP, dibutyryl-cAMP; MGP, amethyl-D-glucopyranoside; OK, opossum kidney; PAH, p-aminohippuric acid.
Methods
This study combined in vitro experiments, conducted in cultured renal cells, and in vivo experiments conducted in rats with various parathyroid status. Materials. Ethanolamine, insulin, transferrin, hydrocortisone, triiodothyronine, a-methyl-D-glucopyranoside (MGP), L-alanine, Daspartate, 1-34 fragment of bovine PTH (bPTH 1-34), Na selenite, dipyridamole, probenecid, p-aminohippuric acid (PAH), amiloride, adenine nucleotides, a,4-methyleneadenosine 5'-diphosphate, bovine serum albumin were purchased from Sigma Chemical Co. (St. Louis, MO). On the day before experiments, culture medium was changed to hormone-free and serum-free medium, and, on the day ofexperiment, preincubations with hormones or nucleotides were usually performed in the same medium to which hormones or drugs were added as concentrated aliquots.
Uptake studies. Uptakes ofPi, MGP, alanine, aspartate, and adenosine were performed as previously described with minor modifications ( 19, 20) . Briefly, uptakes were performed at 37°C in a buffered solution with the following composition (mmol/liter): 137 NaCl, 5. (13) . For these experiments, cells were grown in six-well trays. Incubations with labeled cAMP were performed as described above for uptake studies. At the end ofincubation, a 200-Ml aliquot of medium from each well was transferred to a glass tube containing 3 ml ofice-cold 90% isopropyl alcohol and the remaining medium was aspirated. 1.5 ml of ice-cold 90% isopropyl alcohol were then added to each well. Cells were sonicated in a water bath during 2 min, the extracts were centrifuged to remove proteins, and the supernatants were transferred to glass tubes. This operation was repeated once. Supernatants were pooled, extracts were evaporated to dryness under vacuum, and the residues were dissolved in 100 ,uA of 90% isopropyl alcohol. Aliquots of the isopropanol solutions with appropriate markers were spotted on polyethyleneimine-cellulose sheets with wedged-tip division. The plates were developed for 6 h using a solvent system of95% ethanol/ 5 M ammonium acetate (5:2, vol/vol). After drying, spots were located under ultraviolet light. Average RF values for standards were as follows: uric acid, 0.00; ATP, 0.05; ADP, 0.08; AMP, 0.14; cAMP, 0.40; hypoxanthine-inosine, 0.60; adenosine, 0.68. The reference spots were cut out and removed from the plastic backing by sonication in 2 ml of 0.1 N NaOH, and l-ml aliquots were taken for radioactivity estimation. Recovery of 3H from the plates was > 80%.
In vivo studies. Experiments were performed on 24 male SpragueDawley rats, of average weight 198±8 g. Feeding, anesthesia, infusion (saline, [3H ] inulin, 32p), surgical preparation and clearances were as previously described (9) . Seven groups of rats were studied. In group I, three acutely APTX rats were infused with cAMP, 4 nmol/min per 100 g of body wt after a priming dose of 1 nmol/ 100 g of body wt, after a control period. Group II consisted in three APTX rats, infused with cAMP as in group I; in addition, dipyridamole, 25 gg/min per 100 g of body wt, was infused throughout the experiment. Groups III and IV consisted in APTX rats (n = 3 in each group) infused with dibutyrylcAMP (dBcAMP), 40 nmol/min per 100 g of body wt after a priming dose of 5 nmol/ 100 g ofbody wt, after a control period. Dipyridamole was infused in group IV as in group II. In groups V (n = 5) and VI (n = 3), APTX rats were infused throughout the experiment with bPTH 1-34, 1 U/h per 100 g of body wt. Dipyridamole was infused in group VI at the same rate as in groups II and IV, after a control period without the drug. Finally, group VII consisted of four intact rats receiving a dipyridamole infusion at the same rate as in groups II, IV, and VI, after a control period without the drug.
Presentation ofdata. Uptakes ofPi, MGP, alanine, aspartate, adenosine, and cAMP were expressed as picomoles or nanomoles per milligram of protein (21 ) . Na-dependent uptakes were calculated by subtracting uptake values measured in the presence of N-methyl-D-glucamine from those measured in the presence of Na. Results of in vivo experiments were expressed in terms offractional Pi excretion in urine. Results were presented as mean±SE of three to five different experiments (n) in which duplicates were obtained. One-way or two-way analyses of variance were performed and, when allowed by the Fvalue, results were compared by the modified t test (22) .
Results
Extracellular cAMP uptake and metabolism. Incubation of OK cells with [3H ]cAMP resulted in cellular accumulation of radioactivity which increased linearly with time up to 3 h (Fig.  1 A) . Radioactivity accumulation was decreased in a concentration-dependent manner by RO 20-1724 and probenecid, two documented phosphodiesterase inhibitors (23) (24) (25) (Fig. 1  B) , raising the possibility that extracellular cAMP was degraded into 5'-AMP before uptake. Cell-associated radioactivity, which accumulated mainly through a Na-independent pathway ( Fig. 2 A) , was also decreased by a,,3-methyleneadenosine 5'-diphosphate, a 5'-nucleotidase inhibitor (reviewed in reference 26), and by dipyridamole, which blocks adenosine uptake ( Fig. 2 A) fact that addition of unlabeled adenosine, AMP, or ATP to the incubation medium depressed radioactivity accumulation. In contrast, hypoxanthine, xanthine, and inosine, which do not lead to adenosine formation, were less or not effective (Fig. 2  B) . Cellular accumulation oftritiated material was inhibited in a concentration-dependent manner by cAMP and, to a much lesser extent, by dBcAMP (Table I ). In contrast, cGMP had no effect on radioactivity accumulation while PAH exerted only a modest inhibition at the higher concentration used (1 mM) ( Adenosine uptake. Adenosine uptake by OK cells increased linearly with time up to 20 min of incubation (Fig. 6 ). Uptake was, to a large extent, Na-independent and was blocked by 20 ,uM dipyridamole. Adenosine uptake was not affected by 1 mM probenecid, 100 MM RO 20-1724 , and 1 mM unlabeled cAMP (1.7±0.3, 1.5±0.2, 1.4±0.4, 1.7±0.2 nmol/mg protein per 10 min in control conditions and in the presence of probenecid, RO 20-1724, or cAMP, respectively; not significant). Analysis of intracellular labeled metabolites after adenosine uptake revealed a pattern similar to that observed when cells were incubated with tritiated cAMP (Fig. 4) : accumulated adenosine was converted to ATP and, to a lesser extent, to cAMP. nalysis ofthe kinetic parameters ofNa-independent adenosine uptake was consistent with the existence of one transport system with the following kinetic parameters: Vma = 4.1 nmol/ mg protein per 10 min; Km = 18 ,M (Fig. 7) .
Effect of extracellular cAMP on Na-Pi cotransport in OK cells. Extracellular cAMP decreased Na-dependent Pi uptake in a concentration-and time-dependent manner (Fig. 8) . In subsequent experiments, OK cells were incubated with cAMP or other nucleotides during 3 h.
In order to evaluate whether metabolism of extracellular cAMP influenced its action on Pi uptake, we first studied the effect of the phosphodiesterase inhibitor RO 20-1724. As shown in Table II , RO inhibited concentration-dependently Pi uptake, most likely as a result ofincreased intracellular cAMP accumulation (27, 28) . However, in the presence of RO 20-1724, the inhibitory effect of exogenous cAMP was blunted (Table II) . Similar results were obtained with probenecid (Fig. 9 A) . At 1 mM, probenecid inhibited Pi uptake and blunted to a large extent further inhibition of Pi uptake by extracellular cAMP. Dipyridamole, at 20 MM, suppressed the inhibition ofPi uptake induced by up to 100,uM cAMP (Fig. 9  A) . The results obtained with dibutyryl-cAMP, a permeant, phosphodiesterase-resistant analogue ofcAMP, were strikingly different (Fig. 9 B) . The concentration-dependent inhibition of Pi uptake elicited by dibutyryl-cAMP persisted to a similar extent in the presence of probenecid and dipyridamole, suggesting that, at variance with cAMP, dibutyryl-cAMP entered the cells in intact form. Because PAH was reported, in another system, to compete with cyclic nucleotides for entry in proximal tubular cells ( 12), we evaluated the effect of increasing concentrations of PAH on inhibition by 1 mM cAMP of Nadependent Pi uptake. At the maximal PAH concentration tested, 1 mM, this drug had no intrinsic effect on Pi uptake (5.8±0. out PAH, respectively, n = 3, NS). PAH did not affect the inhibition by cAMP ofPi uptake: cAMP decreased Pi uptake to 2.5±0.3 and 2.8±0.5 nmol/mg protein per 5 min in absence or presence of PAH, respectively (n = 3, NS).
To test further the possibility that the effect of cAMP was exerted, at least in part, by a metabolite ofthe cyclic nucleotide, we examined the effect ofparent compounds on Na-dependent Pi uptake. Incubation of OK cells during 3 h with adenosine, AMP, or ATP, each ofthem at 1 mM, resulted in an inhibition of Pi uptake (Fig. 10, top) . Hypoxanthine, xanthine, and inosine were without effect. In fact, adenosine-induced inhibition of Pi uptake was already maximal at 10 ,uM adenosine (Fig. 10,  bottom) . The effect of adenosine was abolished in the presence of 20 uM dipyridamole.
Finally, we evaluated the effect of RO 20-1724, dipyridamole, and probenecid on PTH-induced inhibition of Pi uptake. As previously reported by others (27, 28) , PTH inhibited Na-dependent Pi uptake in a concentration-dependent man- Results are expressed as means±SE of three different (n = 3) experiments in which duplicates were obtained.
ner (Table III) . RO 20-1724, dipyridamole, or probenecid did not influence the inhibitory effect of PTH.
Effect ofextracellular cAMP on Na-Ala, Na-aspartate and Na-MGP cotransport, and on Na-H exchange in OK cells. To evaluate whether extracellular cAMP affected selectively Na-Pi cotransport, we studied the effect of cAMP and ofactivators of the adenylate cyclase-cAMP system on other Na-coupled uptakes. As shown in Table IV , neither extracellular cAMP nor agents and hormones known to increase intracellular cAMP E/et of/dip'ridamole on Pi 'xcretion n inviv. From in vitro studies on OK cells, it appeared that extracellular cAMP inhibited Pi transport through prior stepwise degradation of the cyclic nucleotide into adenosine followed by adenosine uptake. We tested the involvement of this pathway in vivo by evaluating the effect of dipyridamole infusion, intended to blunt adenosine uptake, on phosphaturia induced by cAMP infusion. As previously reported, infusion of cAMP to APTX rats, at a rate documented to raise plasma cAMP concentration between 1 and 2 ,uM (8), increased FE Pi from 0.05% to 14.5%. When dipyridamole was infused together with cAMP, FE Pi raised to only 1.0% (Fig. 1 1, left panel) . Glomerular filtration rate was not different in the absence ( 1.03±0.12 ml/min per 100 g of body wt) or in the presence of dipyridamole (0.93+0.18 ml/ min per 100 g of body wt, NS). In contrast with the effect of dipyridamole on cAMP-induced phosphaturia, induction of phosphaturia by infusion of the permeant, phosphodiesteraseresistant analog dBcAMP was unchanged by dipyridamole ( Fig. I 1, right panel) .
We next turned to the question of whether nephrogenous cAMP was instrumental in the overall phosphaturic effect of PTH. To answer this question, two sets of experiments were performed. In the first one, PTH-infused APTX rats received dipyridamole or its vehicle. As shown in Fig. 12 (left pantel) dipyridamole decreased significantly Pi excretion. In the second set of experiments, intact rats were infused with dipyridamole. This drug decreased significantly Pi excretion to an extent similar to that observed in PTH-infused APTX rats. (Fig.   12, right panel) . Again, glomerular filtration rate was unaffected by dipyridamole infusion ( 1.28±0.10 vs. 1. 12±0.15 ml/ min per 100 g of body wt, NS). 854 Friedlander et al. OK cells were incubated during 3 h in the absence or presence of bPTH (1-34) and one of the agents at the indicated concentration before Pi uptake (0.1 mM). Results represent means±SE of three different experiments (n = 3) in which duplicates were obtained. PTH, at any concentration tested, inhibited significantly Pi uptake in all experimental conditions (P < 0.01). The magnitude of inhibition was not significantly different whether dipyridamole, probenecid, or RO 20-1724 was present or absent.
Discussion
In the present study, we have demonstrated that: (a) in OK cells, extracellular cAMP was metabolized into adenosine before uptake; (b) in these cells, metabolism of extracellular cAMP into adenosine was a prerequisite to its inhibitory effect on Pi transport; and (c) in vivo, this pathway was involved in the phosphaturic effect of exogenous cAMP and of exogenous or endogenous PTH.
Metabolism of extracellular cAMP precedes uptake. That metabolism of cAMP was a prerequisite to uptake was evidenced by the following: (a) pharmacological inhibition of phosphodiesterases, either by RO 20-1724 (24) or, to a lesser extent, by probenecid (26) , decreased radioactivity accumulation in cells incubated in the presence of labeled cAMP; (b) inhibition of ecto-5'-nucleotidase by a,3-methyleneadenosinediphosphate (26) or of adenosine uptake by dipyridamole ( 14, 17 , and Fig. 6 ) decreased dramatically uptake of labeled cAMP, which strongly suggests that 5'-AMP was further converted into adenosine and that the nucleoside was the uptaken metabolite. This view is supported by the observation that un- labeled adenosine or adenine nucleotides competed with cAMP ( Fig. 2) . That OK cells, which express many features of proximal tubular cells (27) (28) (29) , were able to convert extracellular cAMP into AMP and adenosine on the one hand, and could synthesize ATP and, ultimately, cAMP from uptaken adenosine on the other hand (Fig. 4 ) is in line with previous reports on renal brush border membranes and proximal tubules: rat renal brush-border membranes were reported to express the activity of ecto-enzymes, including phosphodiesterases (30) and 5 '-nucleotidase (3 1 ) responsible for stepwise hydrolysis of adenine nucleotides (32) . Several lines of evidence support the view that intracellularly accumulated [3 
H]cAMP
resulted from intracellular processing of uptaken adenosine:
(a) appearance of [3H ]adenosine in the cell preceeded that of [3H cAMP (Fig. 4) (Fig. 3) , the high-affinity one had a Km value close to that of adenosine uptake (Fig. 7) , a feature consistent with the key role of the adenosine transporter in accumulation of a cAMP metabolite.
Mechanism of extracellular cAMP-induced inhibition of Pi transport. That the effect of cAMP on Pi uptake in OK cells was mediated by adenosine uptake was suggested by the following: (a) inhibition of phosphodiesterases by RO or by probenecid blunted, to a large extent, the effect of cAMP. Intrinsic inhibitory effect of both drugs on Pi uptake (Table II and Fig.  9 ) resulted likely from a decrease of both degradation and efflux of intracellular cAMP (34) . It should be pointed out that the inhibitory effects of100 ,uM (Fig. 11) . It may appear surprising that, at high concentration, the inhibitory effect of adenosine was of smaller magnitude than that of cAMP (Fig.  10 ). This could be accounted for by the documented inhibitory effect of adenosine, at high concentration, on adenosine-kinase which phosphorylates adenosine into AMP within the cell 18), leading ultimately to ATP formation.
Uptake of adenosine issued from metabolism of extracellular cAMP may not have represented the unique way by which high concentrations of cAMP affected Pi uptake. Indeed, at millimolar concentrations, the effect of cAMP was only partially reversed by dipyridamole (Fig. 9 ). This suggests that, besides the adenosine pathway, cAMP might enter cells in intact form through a low-affinity transport system, possibly similar to that involved in cAMP efflux in several cell types (34 (38) . In these conditions, decreased Pi excretion was univocally the reflect of enhanced tubular reabsorption.
As regards the intracellular steps involved in the biological effects of extracellular cAMP beyond adenosine uptake, evidence that de novo ATP synthesis occurred (Fig. 4 ) is in line with the results obtained by Mandel et al. who demonstrated that, in proximal tubules exposed to anoxia, restoration ofATP stores during reoxygenation was dramatically improved when adenosine or adenine nucleotides were present in the extracellular medium ( 18) . That the part ofcellular ATP which serves as substrate for adenylate cyclase may be substantial was evidenced by Kather in adipocytes (39) . In these cells, stimulation of adenylate cyclase by catecholamines decreased ATP content by 33% after 1 h (39). It is therefore reasonable to propose that, given the very rapid ATP turnover in proximal cells (18) , additional ATP synthesis from adenosine might have resulted in additional synthesis of cAMP. As discussed above, both adenylate cyclase and phosphodiesterase activities in proximal cells are high, as evidenced by the effect of imbalance between these two phenomenons during phosphodiesterase inhibition (Fig. 8) . Adenosine, which was also reported to inhibit phosphodiesterases (24, 40) , might have, by this way as well, contributed to inhibit Pi transport. Concerning postcAMP events, they included protein kinase A activation since the effect of extracellular cAMP was blunted in the presence of H8, a protein kinase A inhibitor (not shown).
Involvement of luminal cAMP in the overall phosphaturic effect of PTH. At this point, the question arises of whether extracellular cAMP may play a role in the modulation of renal Pi transport under physiological conditions. Addition ofcAMP to the tubular fluid, which occurs under the influence of PTH in the proximal convoluted tubule (7), combines with water reabsorption to increase cAMP concentration to nearly 150 nM at the end of proximal tubule accessible to micropuncture (7) , that is, at the beginning of the proximal straight tubule, a major site of PTH action on Pi transport (1). We therefore hypothesized that, if cAMP degradation in the lumen was instrumental to modulate Pi transport, dipyridamole, which was shown to block luminal but not basolateral adenosine uptake ( 14) , should decrease Pi excretion. This was indeed the case in both PTH-infused APTX rats and in intact animals ( Fig. 12) , indicating that part ofthe phosphaturic effect ofPTH is, in fact, exerted by extracellular cAMP added to the lumen under the influence of the hormone.
In conclusion, the present study has evidenced that extracellular cAMP inhibition of renal phosphate transport occurred most likely through stepwise hydrolysis of the cyclic nucleotide into adenosine by the brush border membranes, followed by luminal adenosine uptake. Luminal cAMP, added to the tubular fluid under the influence of PTH, accounts for one third of the overall phosphaturic effect of the hormone.
These results bring new insights in the mechanism of PTH modulation of renal Pi transport and may open therapeutic perspectives in hypophosphatemic genetic diseases.
